Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive Lifestyle Intervention with Different Pharmacologic Programs in Type 2 Diabetes
ChiCTR-IPR-15005975Phase 4Recruiting
- Sponsor
- Affiliated Hospital of Nantong University
- Start
- Jan 2015
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of exenatide and insulin lispro mix25 in type 2 diabetes mellitus (T2DM) and Abdominal adiposity (ABCD) (3 arms), sponsored by Affiliated Hospital of Nantong University. Primary endpoint: abdominal visceral adipose tissue areas. Started Jan 2015; status: recruiting.
02
Drugs
exenatideinsulin lispro mix25
03
Conditions
type 2 diabetes mellitus (T2DM)Abdominal adiposity (ABCD)
Beyond the preview
Go deeper on ChiCTR-IPR-15005975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15005975.